ClearPoint Neuro (CLPT) Cash from Investing Activities (2011 - 2026)

ClearPoint Neuro has disclosed Cash from Investing Activities across 15 years of filings, most recently posting -$645000.0 for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$645000.0, down 252.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $153000.0 (up 133.41% YoY), and the FY2025 annual result was $615000.0, up 323.64% from the prior year.
• Cash from Investing Activities came in at -$645000.0 for Q1 2026 at ClearPoint Neuro, down from $1.1 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $11.7 million in Q4 2022 to a low of -$21.7 million in Q2 2022.
• The 5-year median for Cash from Investing Activities is -$185000.0 (2022), against an average of -$139466.7.
• Peak annual rise in Cash from Investing Activities reached 31010.53% in 2022, while the deepest fall reached 62002.86% in 2022.
• ClearPoint Neuro's Cash from Investing Activities stood at $11.7 million in 2022, then tumbled by 101.6% to -$188000.0 in 2023, then slumped by 39.89% to -$263000.0 in 2024, then jumped by 513.69% to $1.1 million in 2025, then plunged by 159.28% to -$645000.0 in 2026.
• The last three Cash from Investing Activities figures came in at -$645000.0 (Q1 2026), $1.1 million (Q4 2025), and -$199000.0 (Q3 2025), per Business Quant data.